Xavier Paoli of Pharnext joined us for World Orphan Drug Congress USA 2015 to present about ‘ Pharnext Pleotherapy Approach in Orphan Neuropathies’
Download the presentation now to learn more about:
- R&D process
- R&D paradigm: pleotherapy
- CMT1A: Slow progressive peripheral neuropathy
- PXT-3003 for the treatment of CMT1A
…and much more!
Get your copy here!
To find out more about how PXT-3003 can aid in the treatment of CMT1A , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.